Skip to content
★ Sign in to follow
Insider activity · 24 months0 buys13 salesCumulative net flow
Total declarations
17
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (13 ops.)
€1.7M

Latest filing published 16 Oct 2026 for MapLight Therapeutics, Inc., €111k.

Filing timeline

BuySale
Erin Pennock Foff

Insider track record

Disclosed buys
0
Disclosed sells
13
Signal history

Erin Pennock Foff: trading record in brief

Erin Pennock Foff discloses dealings in MapLight Therapeutics, Inc. to SEC (Form 4). We count 17 filings; the first trade dates from 27 October 2025 and the latest from 15 October 2026.

Every open-market trade on record is a sale: 13 sales worth €1.7M. Other entries cover 4 share grants. In 2026 alone, the filings show no purchases and 13 sales.

Most recently, on 16 October 2026, the filings show an open-market sale worth €111k in MapLight Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Erin Pennock Foff

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total

17 of 17 declarations